Appili Considers Stock Market Listing

Buoyed by positive results in recent clinical trials, Appili Therapeutics is considering a listing on the Toronto Stock Exchange.
The Halifax-based drug discovery company has been conducting clinical trials on its first drug candidate, ATI-1501, and released a statement today saying the tests produced the results it was hoping for. “It couldn’t have gone any better,” said Vice-President of Drug